Galatzer-Levy IR, Bonanno GA Beyond normality in the study of bereavement: heterogeneity in depression outcomes following loss in older adults. Soc Sci Med. 2012 Jun;74(12):1987-94. doi: 10.1016/j.socscimed.2012.02.022. Epub 2012 Mar 20.
Jonas-Simpson C, Steele R, Granek L, Davies B, O'Leary J Always with me: understanding experiences of bereaved children whose baby sibling died. Death Stud. 2015 Jan-Jun;39(1-5):242-51. doi: 10.1080/07481187.2014.991954. Epub 2014 Dec 31.
Ong AD, Bergeman CS, Bisconti TL, Wallace KA Psychological resilience, positive emotions, and successful adaptation to stress in later life. J Pers Soc Psychol. 2006 Oct;91(4):730-49. doi: 10.1037/0022-3514.91.4.730.
Rosenberg AR, Starks H, Jones B "I know it when I see it." The complexities of measuring resilience among parents of children with cancer. Support Care Cancer. 2014 Oct;22(10):2661-8. doi: 10.1007/s00520-014-2249-5. Epub 2014 Apr 23.
Sanderson C, Lobb EA, Mowll J, Butow PN, McGowan N, Price MA Signs of post-traumatic stress disorder in caregivers following an expected death: a qualitative study. Palliat Med. 2013 Jul;27(7):625-31. doi: 10.1177/0269216313483663. Epub 2013 Apr 11.
Seligman ME Authentic happiness: Using the new positive psychology to realize your potential for lasting fulfillment(Simon and Schuster,2004.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
